why choose us

First received: December 24, 2023

Clinical Trial: PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gout and Hyperuricemia

Study Type: INTERVENTIONAL


Official Title: A Clinical Study Evaluating the Pharmacokinetic Effects of SHR4640 on Repaglinide and Midazolam in Healthy Subjects and the Impact of SHR4640 on QT Interval

Brief Summary: The purpose of this study is to evaluate the PK effects of SHR4640 tablets on repaglinide and midazolam, as well as the effects of SHR4640 tablets on the QT interval in healthy subjects.

Read more